Search results
Showing 286 to 300 of 664 results for kidney or kidneys or renal
Antimicrobial prescribing: oritavancin for acute bacterial skin and skin structure infections (ES39)
Summary of the evidence on oritavancin for acute bacterial skin and skin structure infections (ABSSSI) in adults
Guidance on the use of riluzole (Rilutek) for the treatment of motor neurone disease (TA20)
Evidence-based recommendations on the use of riluzole (Rilutek) for treating motor neurone disease (MND).
NICE has developed a medtech innovation briefing (MIB) on WoundExpress to manage lower leg wounds .
Recommendation ID IPG754/01 Question Percutaneous transluminal renal sympathetic denervation for resistant hypertension should only be...
Cytokine adsorption devices for treating respiratory failure in people with COVID-19 (MIB217)
NICE has developed a medtech innovation briefing (MIB) on cytokine adsorption devices for treating respiratory failure in people with COVID-19 .
In development Reference number: GID-TA11584 Expected publication date: 08 December 2027
Venetoclax with rituximab for previously treated chronic lymphocytic leukaemia (TA561)
Evidence-based recommendations on venetoclax (Venclyxto) with rituximab for previously treated chronic lymphocytic leukaemia in adults.
Glecaprevir–pibrentasvir for treating chronic hepatitis C (TA499)
Evidence-based recommendations on glecaprevir–pibrentasvir (Maviret) for treating chronic hepatitis C in adults.
risk of conditions affecting the eyes and vision, the feet, nerves and kidneys. All of these could lead to complications that could...
on the safety and efficacy of irreversible electroporation for treating renal cancer is inadequate in quantity and quality. Therefore,...
Robot-assisted surgery for orthopaedic procedures: early value assessment (HTE22)
Early value assessment (EVA) guidance on robot-assisted surgery for orthopaedic procedures....
View recommendations for HTE22Show all sections
Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B (TA96)
Evidence-based recommendations on adefovir dipivoxil (Hepsera) and peginterferon alfa-2a (Pegasys) for treating chronic hepatitis B in adults.
Evidence-based recommendations on living-donor liver transplantation. This involves replacing a diseased or damaged liver with a healthy one from a living human donor.
Percutaneous endovascular forearm arteriovenous fistula creation for haemodialysis access (IPG710)
Evidence-based recommendations on percutaneous endovascular forearm arteriovenous fistula creation for haemodialysis access in adults. This involves using radiofrequency energy, or heat and pressure, to join an artery and vein in the forearm to create a fistula for haemodialysis access.
View recommendations for IPG710Show all sections
Discontinued Reference number: GID-TA10166